Press Releases
IntegrateRNA Provided Innovative mRNA Solutions for Research of Life Sciences, Clinical and Drug Development
Jan 7, 2021, 11:27 AM
by
IntegrateRNA, as a mature division of Creative Biogene, is a leading global provider for RNA discovery, expression analysis and function research with unique techniques aims to enable researchers to promote the development of the RNA research field, and explore the world of RNA on an unprecedented scale, and map all RNAs involved in cell life programs, human diseases, and drug discovery. Recently, IntegrateRNA announced the release of its mRNA services in order to accelerate mRNA drugs/vaccines discovery and clinical application.
IntegrateRNA provides customized mRNA synthesis and modification services through in vitro transcription and chemical synthesis. This customized synthesis service is designed to meet the growing demand and the need to deliver mRNA over DNA to mammalian cells for in vitro protein expression, genome editing, mRNA vaccine development, oocyte microinjection and other applications.
The differential expression analysis of cellular mRNA through RNA-seq, microarray and qPCR array enables scientists to screen out genes that play a key role in different life processes. The analysis of mRNA is also widely used in the study of disease pathogenesis and treatment. Based on the theory that mRNA produces protein through translation, the protein can directly treat diseases or act as a vaccine. mRNA designed and synthesized for certain diseases can cause cells to produce protein, and mRNA provides a wide range of opportunities for the treatment and prevention of diseases. prevent disease.
IntegrateRNA provides tailor-made mRNA synthesis for research use, ranging from milligrams to a few grams, up to several thousand bases. It provides many post-transcriptional modifications, including DNase and phosphatase treatments, enzymatic capping and polyadenylation. In addition, customers can choose from a variety of purification options, including silica gel purification, liquid chromatography separation and high-performance liquid chromatography. IntegrateRNA's mRNA service enables researchers to customize synthesis and introduce modifications to produce transcripts most suitable for downstream applications. Methods to produce custom mRNA include chemical synthesis and in vitro transcription.
Meanwhile, IntegrateRNA provides life science and pharmaceutical researchers with a high-throughput quantitative tool for miRNA expression profiling, including complete and customized mRNA qPCR array services from sample to data. IntegrateRNA's service brings together the expertise, performance and function of cDNA synthesis specifically optimized for mRNA characteristics. Scientists will provide a large amount of data and rich analysis to project research into new areas of RNA science and applications.
“Except for the mentioned mRNA services, mRNA Sequencing Service and whole transcriptome sequencing service also are available via IntegrateRNA,” said Marcia Brady, she also claimed, “IntegrateRNA is committed to providing the highest quality products, outstanding service and support, and providing services to users in the fields of life sciences, clinical and drug development. In order to support your research, we can tailor mRNA data analysis channels according to your research interests.”
About IntegrateRNA
IntegrateRNA, as the division of Creative Biogene that holds a leading position in providing complete solutions for RNA research, has years of experience in next-generation sequencing and develops microarray platforms that enable researchers to explore the world of RNA on an unprecedented scale, and mapping all RNAs involved in cell life programs, human diseases, and drug discovery.
IntegrateRNA provides customized mRNA synthesis and modification services through in vitro transcription and chemical synthesis. This customized synthesis service is designed to meet the growing demand and the need to deliver mRNA over DNA to mammalian cells for in vitro protein expression, genome editing, mRNA vaccine development, oocyte microinjection and other applications.
The differential expression analysis of cellular mRNA through RNA-seq, microarray and qPCR array enables scientists to screen out genes that play a key role in different life processes. The analysis of mRNA is also widely used in the study of disease pathogenesis and treatment. Based on the theory that mRNA produces protein through translation, the protein can directly treat diseases or act as a vaccine. mRNA designed and synthesized for certain diseases can cause cells to produce protein, and mRNA provides a wide range of opportunities for the treatment and prevention of diseases. prevent disease.
IntegrateRNA provides tailor-made mRNA synthesis for research use, ranging from milligrams to a few grams, up to several thousand bases. It provides many post-transcriptional modifications, including DNase and phosphatase treatments, enzymatic capping and polyadenylation. In addition, customers can choose from a variety of purification options, including silica gel purification, liquid chromatography separation and high-performance liquid chromatography. IntegrateRNA's mRNA service enables researchers to customize synthesis and introduce modifications to produce transcripts most suitable for downstream applications. Methods to produce custom mRNA include chemical synthesis and in vitro transcription.
Meanwhile, IntegrateRNA provides life science and pharmaceutical researchers with a high-throughput quantitative tool for miRNA expression profiling, including complete and customized mRNA qPCR array services from sample to data. IntegrateRNA's service brings together the expertise, performance and function of cDNA synthesis specifically optimized for mRNA characteristics. Scientists will provide a large amount of data and rich analysis to project research into new areas of RNA science and applications.
“Except for the mentioned mRNA services, mRNA Sequencing Service and whole transcriptome sequencing service also are available via IntegrateRNA,” said Marcia Brady, she also claimed, “IntegrateRNA is committed to providing the highest quality products, outstanding service and support, and providing services to users in the fields of life sciences, clinical and drug development. In order to support your research, we can tailor mRNA data analysis channels according to your research interests.”
About IntegrateRNA
IntegrateRNA, as the division of Creative Biogene that holds a leading position in providing complete solutions for RNA research, has years of experience in next-generation sequencing and develops microarray platforms that enable researchers to explore the world of RNA on an unprecedented scale, and mapping all RNAs involved in cell life programs, human diseases, and drug discovery.
